US FDA will now default to only one clinical trial for drug applications, will this accelerate the release of PP405 and other drugs in clinical trials?
    Research/Science 2/21/2026

    At a glance
    In this general discussion post the tone is 😐 neutral.

    Other terms

    The FDA will now require only one clinical trial for drug approval, potentially speeding up the release of hair loss treatments like PP405. Pelage is expected to present full results of PP405 Phase 2a trials and move to Phase III in mid-2026.
    View this post in the Community →

    Similar Community Posts Join

    5 / 434 results

      community PP405 Update and My Take on Pelage

      in Research/Science  85 upvotes 4 months ago
      Pelage Pharmaceuticals raised $120M for their hair loss treatment, PP405, showing strong investor confidence despite limited data. There is skepticism about its efficacy and long-term effects compared to treatments like GT20029.

      community PP405 - A True Breakthrough or Another Disappointment?

      in Research/Science  34 upvotes 8 months ago
      PP405 shows potential for hair growth, with 31% of advanced balding men experiencing over 20% increase in hair density in 8 weeks. However, skepticism persists due to selective data presentation and lack of long-term results, with comparisons to treatments like minoxidil and finasteride.

      community PP405 is nothing but a scam and Pelage know it.

      in Chat  78 upvotes 6 months ago
      PP405 is criticized for overhyped claims and cherry-picked data, with doubts about its effectiveness compared to minoxidil and finasteride. Many users express skepticism, emphasizing the need for more comprehensive trial results.

    Related Research

    6 / 21 results